Andrew J. Stewart - Apr 24, 2023 Form 3 Insider Report for Bausch & Lomb Corp (BLCO)

Role
Officer
Signature
/s/ Debra E. Levin, attorney-in-fact
Stock symbol
BLCO
Transactions as of
Apr 24, 2023
Transactions value $
$0
Form type
3
Date filed
4/26/2023, 05:14 PM
Next filing
Mar 1, 2024

No securities are beneficially owned.

Remarks:

The Reporting Person's title as an officer of the Issuer is President, Ophthalmic Pharmaceuticals. Exhibit 24 - Power of Attorney